FDA Allow Sponsors to Modify the Conduct of Clinical Trials During the COVID-19 Pandemic
By EsqSocial Corporation 26/03/20
On March 18, the Food and Drug Administration issued a guidance for industry, investigators, and Institutional Review Boards on the “Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic.”...
By: Arnall Golden Gregory LLP